Added to YB: 2019-06-10
Pitch date: 2019-06-10
ACIU [bullish]
AC Immune SA
-49.2%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
Market Cap
$227.4M
Pitch Price
$4.98
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.75
P/E
-3.19
EV/Sales
28.26
Sector
Biotechnology
Category
N/A
Show full summary:
AC IMMUNE SA ACIU
A summary for this pitch has not been created yet.
Read full article (0 min)